🇺🇸 FDA
Pipeline program

DANAZOL , -, -, -, ENTECAVIR , -, VAY736

CVAY736Q12202B

Phase 2 small_molecule active

Quick answer

DANAZOL , -, -, -, ENTECAVIR , -, VAY736 for Immune thrombocytopenia (ITP) Warm autoimmune hemolytic anemia (wAIHA) is a Phase 2 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).

Program details

Company
Novartis Ophthalmics Europe
Indication
Immune thrombocytopenia (ITP) Warm autoimmune hemolytic anemia (wAIHA)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials